NEW YORK, Apr 9: The American College of Physicians (ACP) became the latest group to ask doctors to be clear about the limited benefits and “substantial harms” of prostate cancer screening before offering their male patients a prostate-specific antigen (PSA) test. The ACP’s guidance statement, published Monday in the Annals of Internal Medicine, also explicitly recommends against screening men younger than 50, older than 69 or with less than 10 to 15 years to live. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel